Next Issue
Volume 46, July
Previous Issue
Volume 46, May
 
 
2.9
2.8
Journals
CIMB
Volume 46
Issue 6
share announcement

Curr. Issues Mol. Biol., Volume 46, Issue 6 (June 2024) – 74 articles

Cover Story (view full-size image): Multiple Sclerosis (MS) is the most common demyelinating disease of the central nervous system. MS development and progression depend on the perpetuation of chronic inflammation and high oxidative stress production, which are attributable to several factors, such as infections, an unhealthy diet, autoimmune responses, genetic predisposition, and gut microbiota alterations. In recent years, several studies suggest supplementing traditional treatments with the use of bioactive molecules (e.g., ubiquinone, resveratrol, curcumin, epigallocatechin gallate, citicoline, ellagic acid, boswellic acid, and plant extracts) and dietary interventions (Mediterranean vs. ketogenic) that, acting as antioxidants and anti-inflammatory agents, can help counteract neuroinflammation and oxidative damage. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Previous Issue
Next Issue
Back to TopTop